Similar articles

• [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].

  Feng AM, Wei JY, Yu WJ. Feng AM, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Jul;32(7):473-5. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22213868 Chinese. No abstract available.
• Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.

  Alanio A, Brethon B, Feuilhade de Chauvin M, de Kerviler E, Leblanc T, Lacroix C, Baruchel A, Menotti J. Alanio A, et al. Clin Infect Dis. 2008 May 15;46(10):e116-8. doi: 10.1086/587750. Clin Infect Dis. 2008. PMID: 18419477
• A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.

  Yilmaz D, Balkan C, Ay Y, Akin M, Karapinar B, Kavakli K. Yilmaz D, et al. Mycoses. 2011 May;54(3):234-42. doi: 10.1111/j.1439-0507.2009.01808.x. Mycoses. 2011. PMID: 19906090
• Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.

  Perkhofer S, Lass-Flörl C. Perkhofer S, et al. Expert Opin Investig Drugs. 2009 Sep;18(9):1393-404. doi: 10.1517/13543780903160658. Expert Opin Investig Drugs. 2009. PMID: 19656074 Review.
• Voriconazole: review of a broad spectrum triazole antifungal agent.

  Kofla G, Ruhnke M. Kofla G, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1215-29. doi: 10.1517/14656566.6.7.1215. Expert Opin Pharmacother. 2005. PMID: 15957974 Review.